JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: '4 hqn'

Search results for: '4 hqn'

BA2926 PDK4-IN-1

Summary: PDK4-IN-1 is an anthraquinone derivative and a potent, orally active inhibitor of pyruvate dehydrogenase kinase 4.
BA3406 JKE-1674

Summary: JKE-1674 is an orally active glutathione peroxidase 4 inhibitor and is an active metabolite of an inhibitor ML-210.

≥50.6 mg/mL
BA5065 PF-04995274

Summary: PF-04995274 is a potent, high affinity, orally active partial agonist of the serotonin 4 receptor.
BA5713 BAY-1316957

Summary: BAY-1316957 is a potent, selective, orally active antagonist of prostaglandin E2 receptor subtype 4.
BA7300 Anagliptin

Summary: Anagliptin (SK-0403) is a highly selective, potent, and orally active dipeptidyl peptidase 4 inhibitor.
A4119 AMG-900

Summary: Aurora kinase inhibitor

≥25.2 mg/mL
F1199 Anti-SIRPa/CD172a Antibody (Hospital for Sick Children patent anti-SIRPA)

Summary: Anti-SIRPa/CD172a Antibody (Hospital for Sick Children patent anti-SIRPA)
F1956 Anti-CTLA-4/CD152 Antibody (Antitope patent anti-CTLA4)

Summary: Anti-CTLA-4/CD152 Antibody (Antitope patent anti-CTLA4)
A2174 Lenvatinib (E7080)

Target: VEGFR|PDGFR|RET

Summary: VEGFR inhibitor

≥21.35 mg/mL
A4115 JNJ-7706621
1 Citation

Target: Cyclin-Dependent Kinases|Aurora Kinases

Summary: Potent CDK/Aurora kinase inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.7 mg/mL